{"abstract":"This is a notice, in accordance with 35 U.S.C. 209 and 37 CFR 404, that the National Institute of Drug Abuse, National Institutes of Health, Department of Health and Human Services is contemplating the grant of an exclusive start-up option license to practice the inventions embodied in the following Patent Applications and all related continuing and foreign patents/patent applications for the technology family to EncepHeal Therapeutics, Inc., located in Winston- Salem, North Carolina.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2015/12/22/2015-32141.html","cfr_references":[],"citation":"80 FR 79594","comment_url":null,"comments_close_on":"2016-01-06","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NCI Technology Transfer Center on or before January 6, 2016 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2015-32141","effective_on":null,"end_page":79595,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2015/12/22/2015-32141.xml","html_url":"https://www.federalregister.gov/documents/2015/12/22/2015-32141/prospective-grant-of-an-exclusive-start-up-option-license-potent-and-selective-analogues-of-monamine","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2015-32141?publication_date=2015-12-22","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2015-12-22/2015-32141/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":219,"last_updated":"2026-06-27 08:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2015-12-22/pdf/2015-32141.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2015-32141.pdf?1450705633","publication_date":"2015-12-22","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2015/12/22/2015-32141.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T06:11:58Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":79594,"subtype":null,"title":"Prospective Grant of an Exclusive Start-Up Option License: Potent and Selective Analogues of Monamine Transporters; Methods of Making; and Uses Thereof","toc_doc":"Potent and Selective Analogues of Monamine Transporters; Methods of Making; and Uses Thereof","toc_subject":"Prospective Grants of Exclusive Start-Up Option Licenses:","topics":[],"type":"Notice","volume":80}